Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early surveillance and prophylaxis for Pseudomonas aeruginosa in children with cystic fibrosis
NL-OMON25471Active, not recruiting
- Start
- Jul 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cystic fibrosis (CF) and Pseudomonas aeruginosa airway infection comparing Colistin + ciprofloxacin prophylaxis with Matching placebo (2 arms). Primary endpoint: Early Pseudomonas aeruginosa colonization. Started Jul 2005; status: active, not recruiting.
02
Drugs
colistinciprofloxacin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa airway infection
Beyond the preview
Go deeper on NL-OMON25471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25471.